KALVISTA PHARMACEUTICALS INC Share Price Today: Live Updates & Key Insights

KALVISTA PHARMACEUTICALS INC share price today is $17.34, up 3.47%. The stock opened at $16.73 against the previous close of $16.43, with an intraday high of $17.21 and low of $16.305.

KALVISTA PHARMACEUTICALS INC Share Price Chart

KALVISTA PHARMACEUTICALS INC

us-stock
To Invest in {{usstockname}}
us-stock

KALVISTA PHARMACEUTICALS INC Share Price Performance

$17.34 0.0347(3.47%) KALV at 23 Mar 2026 01:50 PM Biotechnology
Lowest Today 16.305
Highest Today 17.21
Today’s Open 16.73
Prev. Close 16.43
52 Week High 19.00
52 Week Low 9.24
Day’s Range: Low 16.305 High 17.21
52-Week Range: Low 9.24 High 19.00
1 day return -
1 Week return +0.89
1 month return +9.39
3 month return +7.39
6 month return +29.57
1 year return +38.83
3 year return +168.98
5 year return -46.69
10 year return -

KALVISTA PHARMACEUTICALS INC Institutional Holdings

VR Adviser, LLC 13.31

TANG CAPITAL MANAGEMENT LLC 9.97

Frazier Life Sciences Management, L.P. 9.97

Suvretta Capital Management, LLC 9.43

BlackRock Inc 6.18

Millennium Management LLC 5.73

American Funds SMALLCAP World A 5.56

Capital World Investors 5.56

Vanguard Group Inc 4.96

SILVERARC CAPITAL MANAGEMENT, LLC 4.80

Tudor Investment Corp Et AL 3.96

Woodline Partners LP 3.80

Vestal Point Capital LP 3.74

Kynam Capital Management, LP 3.58

The Goldman Sachs Group Inc 3.56

Parkman Healthcare Partners LLC 3.50

State Street Corp 3.12

Vanguard Total Stock Mkt Idx Inv 2.67

Emerald Advisers, LLC 2.65

Octagon Capital Advisors LP 2.52

Schroder Investment Management Group 2.32

International Biotechnology Ord 2.29

State Street® SPDR® S&P® Biotech ETF 2.16

MEDICAL BioHealth EUR Acc 1.94

Geode Capital Management, LLC 1.87

iShares Russell 2000 ETF 1.84

apo Medical Opportunities R 1.46

Vanguard Institutional Extnd Mkt Idx Tr 0.85

Fidelity Small Cap Index 0.74

SEB Läkemedelsfond 0.70

iShares Russell 2000 Growth ETF 0.64

Principal SmallCap Growth I Instl 0.64

Emerald Growth A 0.59

iShares Biotechnology ETF 0.56

State St Russell Sm/Mid Cp® Indx SL Cl I 0.45

F/m Emerald Life Sciences Innovation ETF 0.44

BlackRock Health Sciences Opps Inv A 0.42

Fidelity Extended Market Index 0.41

Schwab US Small-Cap ETF™ 0.37

Vanguard Russell 2000 ETF 0.36

KALVISTA PHARMACEUTICALS INC Market Status

Strong Buy: 7

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

KALVISTA PHARMACEUTICALS INC Fundamentals

Market Cap 859.29 M

PB Ratio 50.5493

PE Ratio 0.0

Enterprise Value 699.71 M

Total Assets 250.77 M

Volume 1382626

KALVISTA PHARMACEUTICALS INC Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:12690000 12.7M

Annual Profit FY25:-941000 -0.9M, FY24:-86167000 -86.2M, FY23:null 0.0M, FY22:null 0.0M, FY21:12690000 12.7M

Annual Net worth FY25:-183444000 -183.4M, FY24:-126644000 -126.6M, FY23:-74853000 -74.9M, FY22:-68512000 -68.5M, FY21:-44494000 -44.5M

Quarterly Revenue Q4/2025:13692000 13.7M, Q3/2025:1426000 1.4M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q4/2024:0 0.0M

Quarterly Profit Q4/2025:12460000 12.5M, Q3/2025:836000 0.8M, Q2/2025:-15891000 -15.9M, Q1/2025:null 0.0M, Q4/2024:null 0.0M

Quarterly Net worth Q4/2025:-49482000 -49.5M, Q3/2025:-60096000 -60.1M, Q2/2025:-52226000 -52.2M, Q1/2025:-48509000 -48.5M, Q4/2024:-42268000 -42.3M

About KALVISTA PHARMACEUTICALS INC & investment objective

Company Information KalVista Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company's product candidate is EKTERLY, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). It develops Factor XIIa, an oral inhibitor for the treatment of HAE which is in preclinical trial. In addition, the company is developing an orally disintegrating tablet formulation, including KONFIDENT-KID for pediatric use with HAE; KONFIDENT-S for adolescent and adult patients with type I or type II HAE; and KONFIDENT for a potential oral therapy for HAE attacks. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts.

Organisation Biotechnology

Employees 270

Industry Biotechnology

CEO Mr. Benjamin L. Palleiko

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

KALVISTA PHARMACEUTICALS INC FAQs

What is the share price of KALVISTA PHARMACEUTICALS INC today?

The current share price of KALVISTA PHARMACEUTICALS INC is $17.34.

Can I buy KALVISTA PHARMACEUTICALS INC shares in India?

Yes, Indian investors can buy KALVISTA PHARMACEUTICALS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy KALVISTA PHARMACEUTICALS INC shares in India?

You can easily invest in KALVISTA PHARMACEUTICALS INC shares from India by:

Can I buy fractional shares of KALVISTA PHARMACEUTICALS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of KALVISTA PHARMACEUTICALS INC?

KALVISTA PHARMACEUTICALS INC has a market cap of $859.29 M.

In which sector does KALVISTA PHARMACEUTICALS INC belong?

KALVISTA PHARMACEUTICALS INC operates in the Biotechnology sector.

What documents are required to invest in KALVISTA PHARMACEUTICALS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of KALVISTA PHARMACEUTICALS INC?

The PE ratio of KALVISTA PHARMACEUTICALS INC is N/A and the PB ratio is 50.55.